Condition
Drug Coated Balloon clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Drug Coated Balloon clinical trials that are recruiting, at sites in 6 countries (most in Estonia (1), China (1), Belgium (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 6Countries
Newest Drug Coated Balloon clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease | — | Chuzhou, Anhui and 6 other locations | Recruiting | Aug 13, 2026 |
| Crystalline sirolimus-coated balloon for treating coronary artery disease | — | Vigo, Pontevedra | Recruiting | Mar 3, 2026 |
| Long Passeo-18 Lux balloon for leg artery blockages | — | Aalst and 3 other locations | Recruiting | Feb 4, 2026 |
| Outcomes after PCI using the Protégé paclitaxel drug-coated balloon. | — | Amsterdam | Recruiting | Nov 17, 2025 |
| Drug-coated balloon with bail-out bioresorbable scaffold versus scaffold alone for new coronary artery blockages | — | Tallinn | Recruiting | Jun 26, 2025 |
| Evaluating drug-coated balloons for new coronary artery lesions | — | Ulsan | Recruiting | Nov 6, 2020 |
All recruiting trials (6)
-
Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease
This registry tests whether delivery time and inflation duration of drug-coated balloons affect outcomes in adults undergoing PCI for new coronary lesions.
-
Crystalline sirolimus-coated balloon for treating coronary artery disease
This tests whether a crystalline sirolimus-coated balloon is safe and effective for adults having percutaneous coronary intervention for coronary artery blockages or in-stent restenosis.
-
Long Passeo-18 Lux balloon for leg artery blockages
A single-arm trial tests a long paclitaxel-releasing balloon to treat new or recurring leg artery blockages in adults.
-
Outcomes after PCI using the Protégé paclitaxel drug-coated balloon.
This registry will collect real-world data to see if the Protégé paclitaxel drug-coated balloon works well and is safe for adults having PCI for coronary artery disease or acute coronary syndrome.
-
Drug-coated balloon with bail-out bioresorbable scaffold versus scaffold alone for new coronary artery blockages
This test sees if using a drug-coated balloon with bail-out bioresorbable scaffold works as well as using a bioresorbable scaffold alone for adults 18–68 getting PCI for new coronary artery blockages, including certain heart attacks and unstable angina.
-
Evaluating drug-coated balloons for new coronary artery lesions
This study is testing whether drug-coated balloons can safely and effectively treat new coronary artery blockages better than traditional methods like regular balloon angioplasty and drug-eluting stents.
Related topics
Quick answers
How many Drug Coated Balloon clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Estonia (1 trial), China (1 trial), Belgium (1 trial), Spain (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.